WestBIC, CÚRAM, the Science Foundation Ireland Research Centre for Medical Devices at NUI Galway, and their European partners in Codex4SMEs Information and Networking Event are to host the Interreg North-West Europe project Codex4SMEs (Companion Diagnostics Expedited for Small and Medium-sized Enterprises) on Wednesday, 18 September, at Hotel Meyrick, Galway. Read More
Atriva Therapeutics GmbH, a biopharmaceutical company pioneering the development of host-targeting antiviral therapies, today announced that they have received the Biomarker Validation Award as part of the European Interreg Project Codex4SME. A total of four award winners will receive a grant of approximately 100,000 Euros each, in the form of laboratory services by the Integrated Biobank of Luxembourg. Read More
Four companies from Germany, France and the Netherlands have been presented with the Biomarker Validation Award as part of Codex4SMEs. The European project aims to establish a transnational network to accelerate the development of companion diagnostics along the entire value chain of small and medium-sized enterprises. The award is endowed with approximately EUR 100,000, which is handed over in the form of laboratory services. The chosen companies can now have their respective biomarkers validated by the Integrated Biobank of Luxembourg – in other words, have them tested to assess their reliability with regard to their relevant indication. Read More
The Interreg project Codex4SMEs (Companion diagnostics expedited for small and medium-sized businesses) project plans to improve healthcare by enhanced adoption of Personalized Medicine in North-West Europe. The objective is to establish a network, which supports SMEs along the value chain of Companion diagnostics (Cdx) development. Read More
Finding capital to fund your (companion) diagnostics SME: The Venture Capital perspective. On 28 May, a web seminar with Tom Miller in the frame of the Interreg NWE project 'Codex4SMEs' took place. Tom Miller is founder of Greybird Ventures and is dedicated to invest in companies that can help to eliminate "trial and error" medicine with high-specifity diagnostics and generate value for patients, providers, developers of therapies, and those who pay for healthcare. Read More
Finding capital to fund your (companion) diagnostics SME: The Venture Capital perspective. The Interreg NWE project 'Codex4SMEs' proudly announces an online event with Tom Miller, founder of Greybird Ventures, who is dedicated to invest in companies that can help to eliminate "trial and error" medicine with high-specifity diagnostics and generate value for patients, providers, developers of therapies, and those who pay for healthcare. Read More
Please find the presentations of the speakers from the double session event in Luxembourg within this News-notification. Read More
The Leiden based biotechnology firm Idris Oncology is one of the three SME’s in Europe to receive human tissue through the Codex4SME’s consortium, in order to help them progress their diagnostic product towards clinical application. Interreg project Codex4SME's supports entrepreneurs in Life Sciences & Health sector in obtaining human tissue from biobanks. The application process for tissue can be very lingering and complicated. Read More
IBBL (Integrated Biobank of Luxembourg) is pleased to be hosting the second Codex4SMEs double session at its premises in Dudelange, Luxembourg. The meeting will allow SMEs from the partner regions to discover the biomarker validation services offered by IBBL as well as the support ecosystem that Luxembourg can provide. Read More
Take the chance and get to know more about sample quality and quality control. The Biobank of Graz is going to present an online event addressing theses issues next Thursday on January 17th! Please find more information and the registration link under the tab 'Events'. Read More
